MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3

References

• Park JW, Chen M, Colombo M, et al.Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155–2166. doi:10.1111/liv.1281825752327
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2129425651787
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-023245604
   PubMed Web of Science ®Google Scholar
• Ringelhan M, O’Connor T, Protzer U, Heikenwalder M The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. J Pathol. 2015;235(2):355–367. doi:10.1002/path.443425196558
   PubMed Web of Science ®Google Scholar
• Thorgeirsson SS, Stemness in Liver Cancer. Dig Dis, 2017 35(4): p. 387–389. doi:10.1159/000456592
   PubMed Web of Science ®Google Scholar
• Han R, Li S Regorafenib delays the proliferation of hepatocellular carcinoma by inducing autophagy. Pharmazie. 2018;73(4):218–222.29609689
   PubMed Web of Science ®Google Scholar
• Sim HW, Knox J Hepatocellular carcinoma in the era of immunotherapy. Curr Probl Cancer. 2018;42(1):40–48. doi:10.1016/j.currproblcancer.2017.10.00729150141
   PubMed Web of Science ®Google Scholar
• Tryndyak VP, Ross SA, Beland FA, Pogribny IP Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. Mol Carcinog. 2009;48(6):479–487. doi:10.1002/mc.2048418942116
   PubMed Web of Science ®Google Scholar
• Ren FH, Yang H, He RQ, et al.Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma. BMC Cancer. 2018;18(1):12. doi:10.1186/s12885-018-4242-829298665
   PubMedGoogle Scholar
• Chen Q, Li L, Tu Y, et al.MiR-34a regulates apoptosis in liver cells by targeting the KLF4 gene. Cell Mol Biol Lett. 2014;19(1):52–64. doi:10.2478/s11658-013-0115-y24415058
   PubMed Web of Science ®Google Scholar
• Li J, Lam M. Reproducibility project: cancer B. Registered report: the microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Elife. 2015;4:e06434. doi:10.7554/eLife.0641626231042
   PubMed Web of Science ®Google Scholar
• Li R, Shi X, Ling F, et al.MiR-34a suppresses ovarian cancer proliferation and motility by targeting AXL. Tumour Biol. 2015;36(9):7277–7283. doi:10.1007/s13277-015-3445-825895459
   PubMedGoogle Scholar
• Craig VJ, Tzankov A, Flori M, Schmid CA, Bader AG, Muller A Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo. Leukemia. 2012;26(11):2421–2424. doi:10.1038/leu.2012.11022522790
   PubMed Web of Science ®Google Scholar
• Wiggins JF, Ruffino L, Kelnar K, et al. Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 2010;70(14):5923–5930. doi:10.1158/0008-5472.CAN-10-065520570894
   PubMed Web of Science ®Google Scholar
• Beg MS, Brenner AJ, Sachdev J, et al. (2017). Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors. Invest New Drugs. 35(2): 180–188. doi:10.1007/s10637-016-0407-y27917453
   PubMed Web of Science ®Google Scholar
• Gaubatz S, Lindeman GJ, Ishida S, et al. E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. Mol Cell. 2000;6(3):729–735. doi:10.1016/S1097-2765(00)00071-X11030352
   PubMed Web of Science ®Google Scholar
• Carr SM, Poppy Roworth A, Chan C, La Thangue NB Post-translational control of transcription factors: methylation ranks highly. FEBS J. 2015;282(23):4450–4465. doi:10.1111/febs.1352426402372
   PubMed Web of Science ®Google Scholar
• Sun CC, Zhou Q, Hu W, et al. Transcriptional E2F1/2/5/8 as potential targets and transcriptional E2F3/6/7 as new biomarkers for the prognosis of human lung carcinoma. Aging (Albany NY). 2018;10(5):973–987. doi:10.18632/aging.10144629754146
   PubMedGoogle Scholar
• Tazawa H, Tsuchiya N, Izumiya M, Nakagama H Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104(39):15472–15477. doi:10.1073/pnas.070735110417875987
   PubMed Web of Science ®Google Scholar
• Tammali R, Saxena A, Srivastava SK, Ramana KV Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology. 2010;151(5):2140–2150. doi:10.1210/en.2010-041220308528
   PubMed Web of Science ®Google Scholar
• Shan ZN, Tian R, Zhang M, et al.miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3. Oncotarget. 2016;7(48):78813–78826. doi:10.18632/oncotarget.1238527705931
   PubMedGoogle Scholar
• Santos M, Martinez-Fernandez M, Duenas M, et al. In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer. Cancer Res. 2014;74(22):6565–6577. doi:10.1158/0008-5472.CAN-13-351425252918
   PubMed Web of Science ®Google Scholar
• Suzuki T, Yasui W, Yokozaki H, Naka K, Ishikawa T, Tahara E Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer. 1999;81(4):535–538.10225440
   PubMed Web of Science ®Google Scholar
• Huang CL, Liu D, Nakano J, et al. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer. Clin Cancer Res. 2007;13(23):6938–6946. doi:10.1158/1078-0432.CCR-07-153918056168
   PubMed Web of Science ®Google Scholar
• Kent LN, Bae S, Tsai SY, et al. Dosage-dependent copy number gains in E2F1 and E2F3 drive hepatocellular carcinoma. J Clin Invest 2017;127(3):830–842. doi:10.1172/JCI8758328134624
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang M, Shi C, Shi F, Pei C Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Biosci Trends. 2018;12(3):309–316. doi:10.5582/bst.2018.0105229952351
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang W, Zhang Y, Wang Y, Liu M, Liu Y Effects of Spica prunellae on caspase-3-associated proliferation and apoptosis in human lung cancer cells in vitro. J Cancer Res Ther. 2018;14(4):760–763. doi:10.4103/jcrt.JCRT_1289_1629970649
   PubMed Web of Science ®Google Scholar
• Cui R, Meng W, Sun HL, et al.MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer. Proc Natl Acad Sci USA 2015;112(31):E4288–97. doi:10.1073/pnas.150206811226187928
   PubMed Web of Science ®Google Scholar
• Brown MF, Leibowitz BJ, Chen D, et al.Loss of caspase-3 sensitizes colon cancer cells to genotoxic stress via RIP1-dependent necrosis. Cell Death Dis. 2015;6:e1729.25906152
   PubMed Web of Science ®Google Scholar
• Xiang W, Lin H, Wang Q, et al.miR34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3. Mol Med Rep. 2016;14(6):5049–5056. doi:10.3892/mmr.2016.590127840975
   PubMed Web of Science ®Google Scholar
• Liu X, Wu X Utilizing matrigel transwell invasion assay to detect and enumerate circulating tumor cells. Methods Mol Biol. 2017;1634:277–282.28819859
   PubMedGoogle Scholar
• Lin M, Tang S, Zhang C, et al.Euphorbia factor L2 induces apoptosis in A549 cells through the mitochondrial pathway. Acta Pharm Sin B. 2017;7(1):59–64. doi:10.1016/j.apsb.2016.06.00828119809
   PubMed Web of Science ®Google Scholar
• Pulikkan JA, Peramangalam PS, Dengler V, et al.C/EBPalpha regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations. Blood. 2010;116(25):5638–5649. doi:10.1182/blood-2010-04-28160020889924
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.03515652477
   PubMed Web of Science ®Google Scholar
• Adams BD, Parsons C, Slack FJ The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas. Expert Opin Ther Targets. 2016;20(6):737–753. doi:10.1517/14728222.2016.111410226652031
   PubMed Web of Science ®Google Scholar
• Sun TY, Xie HJ, Li Z, et al.miR-34a regulates HDAC1 expression to affect the proliferation and apoptosis of hepatocellular carcinoma. Am J Transl Res. 2017;9(1):103–114.28123637
   PubMed Web of Science ®Google Scholar
• Chen R, Zhu D, Ye X, Shen D, Lu R Establishment of three human liver carcinoma cell lines and some of their biological characteristics in vitro. Sci Sin. 1980;23(2):236–247.6154311
   PubMedGoogle Scholar
• Xiao Z, Li CH, Chan SL, et al.A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma. Cancer Res. 2014;74(21):6236–6247. doi:10.1158/0008-5472.CAN-13-351425217526
   PubMed Web of Science ®Google Scholar
• Daige CL, Wiggins JF, Priddy L, Nelligan-Davis T, Zhao J, Brown D Systemic delivery of a miR34a mimic as a potential therapeutic for liver cancer. Mol Cancer Ther. 2014;13(10):2352–2360. doi:10.1158/1535-7163.MCT-14-020925053820
   PubMed Web of Science ®Google Scholar
• Xiao Z, Li CH, Chan SL, et al.A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma. Cancer Res. 2014;74(21):6236–6247. doi:10.1158/0008-5472.CAN-13-351425217526
   PubMed Web of Science ®Google Scholar
• Jiang ZC, Tang XM, Zhao YR, Zheng L A functional variant at miR-34a binding site in toll-like receptor 4 gene alters susceptibility to hepatocellular carcinoma in a Chinese Han population. Tumour Biol. 2014;35(12):12345–12352. doi:10.1007/s13277-014-2547-z25179842
   PubMedGoogle Scholar
• Dang Y, Luo D, Rong M, Chen G Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET. PLoS One. 2013;8(4):e61054. doi:10.1371/journal.pone.006105423593387
   PubMed Web of Science ®Google Scholar
• Tammali R, Saxena A, Srivastava SK, Ramana KV Aldose reductase regulates vascular smooth muscle cell proliferation by modulating G1/S phase transition of cell cycle. Endocrinology. 2010;151(5):2140–2150. doi:10.1210/en.2010-041220308528
   PubMed Web of Science ®Google Scholar
• Lee M, Oprea-Ilies G, Saavedra HI Silencing of E2F3 suppresses tumor growth of Her2+ breast cancer cells by restricting mitosis. Oncotarget. 2015;6(35):37316–37334. doi:10.18632/oncotarget.568626512919
   PubMedGoogle Scholar
• Wei WY, Yan LH, Wang XT, et al.E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo. World J Gastroenterol. 2015;21(2):491–501. doi:10.3748/wjg.v21.i10.293725593464
   PubMed Web of Science ®Google Scholar
• Fang Z, Gong C, Liu H, et al.E2F1 promote the aggressiveness of human colorectal cancer by activating the ribonucleotide reductase small subunit M2. Biochem Biophys Res Commun. 2015;464(2):407–415. doi:10.1016/j.bbrc.2015.06.15726093293
   PubMed Web of Science ®Google Scholar
• Polager S, Ginsberg D p53 and E2f: partners in life and death. Nat Rev Cancer. 2009;9(10):738–748. doi:10.1038/nrc271819776743
   PubMed Web of Science ®Google Scholar
• Gala S, Marreiros A, Stewart GJ, Williamson P Overexpression of E2F-1 leads to cytokine-independent proliferation and survival in the hematopoietic cell line BaF-B03. Blood. 2001;97(1):227–234.11133765
   PubMed Web of Science ®Google Scholar
• Zauli G, Voltan R, Di Iasio MG, et al. miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. Clin Cancer Res. 2011;17(9):2712–2724. doi:10.1158/1078-0432.CCR-10-324421367750
   PubMed Web of Science ®Google Scholar
• Atkinson EA, Barry M, Darmon AJ, et al. Cytotoxic T lymphocyte-assisted suicide. Caspase 3 activation is primarily the result of the direct action of granzyme B J Biol Chem. 1998;273(33):21261–21266. doi:10.1074/jbc.273.33.212619694885
   PubMed Web of Science ®Google Scholar
• Huang Q, Zheng Y, Ou Y, et al.miR-34a/Bcl-2 signaling pathway contributes to age-related hearing loss by modulating hair cell apoptosis. Neurosci Lett 2017;661:51–56. doi:10.1016/j.neulet.2017.07.04428756190
   PubMed Web of Science ®Google Scholar
• Noble P, Vyas M, Al-Attar A, Durrant S, Scholefield J, Durrant L High levels of cleaved caspase-3 in colorectal tumour stroma predict good survival. Br J Cancer. 2013;108(10):2097–2105. doi:10.1038/bjc.2012.49423591201
   PubMed Web of Science ®Google Scholar
• Jakubowska K, Guzinska-Ustymowicz K, Famulski W, Cepowicz D, Jagodzinska D, Pryczynicz A Reduced expression of caspase-8 and cleaved caspase-3 in pancreatic ductal adenocarcinoma cells. Oncol Lett. 2016;11(3):1879–1884. doi:10.3892/ol.2016.409926998093
   PubMed Web of Science ®Google Scholar
• Zhou Y, Xiong M, Niu J, et al.Secreted fibroblast-derived miR-34a induces tubular cell apoptosis in fibrotic kidney. J Cell Sci. 2014;127(Pt 20):4494–4506. doi:10.1242/jcs.15405425107369
   PubMed Web of Science ®Google Scholar
• Ding N, Wu H, Tao T, Peng E NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p/BCL2. Onco Targets Ther. 2017;10:4905–4915. doi:10.2147/OTT.S14244629062236
   PubMed Web of Science ®Google Scholar
• Li LH, Tu QY, Deng XH, et al.Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells. Brain Res. 2017;1662:57–64. doi:10.1016/j.brainres.2017.01.03428189560
   PubMed Web of Science ®Google Scholar
• Kaneda H, Tamura K, Kurata T, Uejima H, Nakagawa K, Fukuoka M Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer. Lung Cancer. 2004;46(2):247–254. doi:10.1016/j.lungcan.2004.04.03215474673
   PubMed Web of Science ®Google Scholar
• Wang C, Wang MD, Cheng P, et al.Hepatitis B virus X protein promotes the stem-like properties of OV6(+) cancer cells in hepatocellular carcinoma. Cell Death Dis. 2017;8(1):e2560. doi:10.1038/cddis.2017.51828102846
   PubMedGoogle Scholar
• Choi BH, Choi M, Jeon HY, Rho HM Hepatitis B viral X protein overcomes inhibition of E2F1 activity by pRb on the human Rb gene promoter. DNA Cell Biol. 2001;20(2):75–80. doi:10.1089/10445490175007027411244564
   PubMed Web of Science ®Google Scholar
• Jung JK, Arora P, Pagano JS, Jang KL Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res. 2007;67(12):5771–5778. doi:10.1158/0008-5472.CAN-07-052917575144
   PubMed Web of Science ®Google Scholar
• Chen X, Cheung ST, So S, et al. Gene expression patterns in human liver cancers. Mol Biol Cell. 2002;13(6):1929–1939. doi:10.1091/mbc.e02-03-015712058060
   PubMed Web of Science ®Google Scholar
• Roessler S, Jia HL, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202–10212. doi:10.1158/0008-5472.CAN-10-260721159642
   PubMed Web of Science ®Google Scholar
• Wurmbach E, Chen YB, Khitrov G, et al. Genome wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007;45(4):938–947. doi:10.1002/hep.2162217393520
   PubMed Web of Science ®Google Scholar
• Mas VR, Maluf DG, Archer KJ, et al. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med. 2009;15(3–4):85–94. doi:10.2119/molmed.2008.0011019098997
   PubMed Web of Science ®Google Scholar